02/25/2026
π£π£ HELP SHAPE LONG COVID RESEARCH π£π£
In 2021, Dr. Luke Liu & Dr. Deborah Duricka introduced Stellate Ganglion Block (SGB) as a potential treatment for Long COVID in a landmark publication. Since then, Dr. Liu has worked tirelessly to advocate for multicenter clinical trials and encourage major institutions to undertake them, aiming to generate the evidence needed to make this treatment available to more patients worldwide. With the help of patients, caregivers, providers, and advocates, NIH's RECOVER-TLC initiative is currently designing a multicenter clinical trial to study SGB as a potential treatment for Long COVID.
π£Now, the RECOVER-TLC team needs your voice! π£ They are currently seeking public feedback on the clinical trial protocol.
Whether you are a patient, caregiver, or healthcare provider, your input ensures this research is designed with the community's needs in mind.
β°οΈ Deadline: Feedback must be submitted by Sunday, March 8th.
How to participate:
1. Register first: If you haven't already, sign up via the RECOVER-TLC Registration Form.
2. Check your email: You'll receive a welcome link shortly after registering.
3. Submit feedback: Log in to the RECOVER-TLC Collaborator Portal to read the trial summary and share your thoughts.
All responses are confidential. For more details on the mission behind these trials, check out the FNIH RECOVER-TLC FAQ page.
https://fnih.org/our-programs/recover-tlc-will-advance-long-covid-research/recover-tlc-faqs/
Please share this post to help us reach as many voices as possible π©΅